CIK 0001768224
- Accelerated filer
- Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 858-900-2660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | HOLMES EDWARD W Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-09 | HOLMES EDWARD W Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-14 | HOLMES EDWARD W Director | Exercise or conversion | +3,131 | 3,131 | ||
| 2024-06-14 | HOLMES EDWARD W Director | Exercise or conversion · Deferred Stock Units | −3,131 | 0 | ||
| 2024-06-14 | HOLMES EDWARD W Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2023-08-01 | HOLMES EDWARD W Director | Grant or award · Stock Option (right to buy) | +11,869 | 11,869 | ||
| 2023-08-01 | HOLMES EDWARD W Director | Grant or award · Deferred Stock Units | +3,131 | 3,131 | ||
| 2022-06-23 | HOLMES EDWARD W Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-06-18 | HOLMES EDWARD W Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-06-22 | HOLMES EDWARD W Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-10-25 | HOLMES EDWARD W Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-10-25 | HOLMES EDWARD W Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 1 of 1 · 12 trades